Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNET 5 MB Trial for Medulloblastoma in Children
NCT02066220Phase 3Active, not recruiting
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jun 2014
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Targeted Liposomes
- Countries
- 16
01
Overview
A Phase 3 trial of carboplatin, Cisplatin micelle injection (HA132), lomustine, vincristine sulfate liposome injection, cyclophosphamide in medulloblastoma, sponsored by University Medical Center Hamburg-Eppendorf. Started Jun 2014; status: active, not recruiting.
02
Drugs
carboplatinCisplatin micelle injection (HA132)lomustinevincristine sulfate liposome injectioncyclophosphamide
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT02066220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066220.